Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Melanoma Research Alliance Announces 13 Dermatology Fellowship Awards
12:00am, Thursday, 08'th Oct 2020
The Melanoma Research Alliance, the largest non-profit funder of melanoma research, has named 13 promising clinicians/researchers-in-training as 2020
Oct 01, 2020 (The Expresswire) --
“Melanoma Therapeutics Market" report provides a detailed evaluation of the market by highlighting information on different...
Oct 01, 2020 (The Expresswire) --
Global "Melanoma Therapeutics Market" 2020 report includes the market strategy, market orientation, expertise opinion and...
Oct 01, 2020 (The Expresswire) --
Global "Melanoma Therapeutics Market" 2020 report includes the market strategy, market orientation, expertise opinion and...
Oct 01, 2020 (The Expresswire) --
Global "Melanoma Therapeutics Market" 2020 report includes the market strategy, market orientation, expertise opinion and...
TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate
12:00am, Thursday, 24'th Sep 2020
TriSalus Life Sciences announces its therapeutic clinical development strategy following the acquisition of SD-101, from Dynavax Technologies.
Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced approval for the latest version of its next-gen
Daniel Bradbury Sells 3,750 Shares of Castle Biosciences (NASDAQ:CSTL) Stock
07:18am, Saturday, 22'nd Aug 2020
Castle Biosciences (NASDAQ:CSTL) Director Daniel Bradbury sold 3,750 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $43.18, for
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
10X Genomics Inc (NASDAQ: TXG)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Avenue Therapeutics Inc (NASDAQ: ATXI)...
A Closer Look At Castle Biosciences, Inc.'s (NASDAQ:CSTL) Uninspiring ROE
01:03pm, Tuesday, 11'th Aug 2020
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
10:25pm, Monday, 10'th Aug 2020
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 80.95% and 39.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock
Castle Biosciences Announces Second Quarter 2020 Results
08:05pm, Monday, 10'th Aug 2020
Castle Biosciences today announced its financial results for the second quarter and six months ended June 30, 2020.
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Castle Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
11:00am, Wednesday, 05'th Aug 2020
Castle Biosciences is scheduled to present a company overview at the Canaccord Genuity 40th Annual Growth Conference on Wednesday, August 12, 2020.
